Everlab Secures $10M: Reshaping Healthcare with AI-Powered Prevention
July 26, 2025, 9:33 am
Everlab secured $10M seed funding. This AI-powered health platform revolutionizes preventive care. It combines advanced diagnostics with intelligent insights. The goal is to combat chronic disease proactively. It offers personalized plans, freeing physicians. Expansion is set to deliver scalable, early interventions globally. This new model transforms reactive healthcare into a precision-driven, proactive system. It targets better health outcomes for millions.
Modern healthcare faces a critical challenge. It is largely reactive. It treats illness after it strikes. This model strains resources. It often delivers care too late. Chronic diseases dominate global mortality. Over 70% of deaths link to these conditions. Yet, proactive prevention remains out of reach for many. Early detection and personalized care are vital. They save lives. They reduce long-term costs. A systemic shift is urgent.
Everlab leads this critical transformation. The company recently announced a significant financial milestone. It secured a US$10 million seed funding round. Left Lane Capital, a global growth equity firm, led the investment. This funding signals strong confidence in Everlab's vision. It validates a new paradigm in health technology.
The investment fuels strategic expansion. Everlab targets international markets. It will accelerate its proprietary AI healthtech platform development. A deeply integrated product ecosystem will emerge. This system aims to deliver lifelong, proactive health management. It moves beyond traditional episodic care.
Everlab’s model stands apart. It offers a tiered membership structure. This combines comprehensive advanced diagnostics. Digital-first doctor consultations provide expert guidance. Intelligent health insights complete the picture. The platform delivers personalized prevention. It scales effectively.
Members access an array of sophisticated screenings. This includes advanced blood testing. Whole-body MRIs offer detailed views. DEXA scans assess bone density. VO2 max measures cardiovascular fitness. ECGs monitor heart health. Isometric strength tests gauge physical capacity. Continuous glucose monitoring tracks metabolic health. Food journal analysis refines dietary habits. CT coronary angiograms detect heart issues early. These diagnostics pair with continuous support. Members receive personalized prevention plans. The flagship Protocol membership exemplifies this. It provides year-round diagnostics. Clinically guided interventions follow. This comprehensive approach comes at a fraction of traditional care costs. It makes premium prevention accessible.
At Everlab’s core lies its proprietary clinical platform. This full-stack system leverages powerful AI agents. These agents ingest vast amounts of complex health data. They analyze and interpret this information. The AI automates clinical summaries. It identifies early risk markers. It recommends precise next steps. This frees physicians from administrative burdens. Doctors focus on patient care. They deliver earlier, more precise interventions.
Deep integrations connect Everlab to the existing healthcare infrastructure. It links with national pathology networks. It integrates with radiology networks. This creates a real-time, longitudinal health record for every member. The platform seamlessly embeds within the current system. It enhances, not replaces, clinical workflows.
Everlab’s early momentum is impressive. Tens of thousands of customers populate its waitlist. Demand grows across consumer and enterprise markets. The company projects twenty-fold growth this year. Its go-to-market strategy positions Everlab as a leader. It delivers high-quality, prevention-focused care at scale.
The impact of Everlab’s approach is tangible. The company has processed over 1,000,000 biomarkers. These come from full-body health testing. The findings are sobering. One in four test results show abnormalities. For 2.5% of members, discoveries are life-changing. These include blocked arteries. Gastrointestinal tumors have been found. Early-stage cancers and congenital brain abnormalities surface. Early detection leads to timely treatment. This saves lives.
Beyond diagnostics, Everlab provides data-driven interventions. These are highly personalized. They align with each member’s risk profile. They target individual health goals. Retesting reveals significant improvements. A meta-analysis of members showed progress. Over one-third of modifiable biomarkers improved within six months. This demonstrates the model’s concrete health impact. Everlab transitions individuals from at-risk to healthier states.
The new funding round ensures continued progress. Everlab will expand its clinic network. It will grow its engineering team. Its clinical team will also expand. The company will advance its AI-powered infrastructure. This lays the foundation for a truly global system. It builds scalable preventive healthcare. Everlab transforms medical ideals into commercial reality. It combines clinical depth with software leverage. Operational precision makes it scalable. The company builds a category-defining platform. It sets a new standard for proactive health management.
Everlab heralds a new era in health. It moves healthcare from reactive treatment to proactive prevention. It harnesses AI. It empowers individuals. It supports clinicians. The focus shifts to lifelong wellness. This innovative model promises to redefine health outcomes for millions globally. It makes personalized, preventive care accessible. This is the future of health.
Modern healthcare faces a critical challenge. It is largely reactive. It treats illness after it strikes. This model strains resources. It often delivers care too late. Chronic diseases dominate global mortality. Over 70% of deaths link to these conditions. Yet, proactive prevention remains out of reach for many. Early detection and personalized care are vital. They save lives. They reduce long-term costs. A systemic shift is urgent.
Everlab leads this critical transformation. The company recently announced a significant financial milestone. It secured a US$10 million seed funding round. Left Lane Capital, a global growth equity firm, led the investment. This funding signals strong confidence in Everlab's vision. It validates a new paradigm in health technology.
The investment fuels strategic expansion. Everlab targets international markets. It will accelerate its proprietary AI healthtech platform development. A deeply integrated product ecosystem will emerge. This system aims to deliver lifelong, proactive health management. It moves beyond traditional episodic care.
Everlab’s model stands apart. It offers a tiered membership structure. This combines comprehensive advanced diagnostics. Digital-first doctor consultations provide expert guidance. Intelligent health insights complete the picture. The platform delivers personalized prevention. It scales effectively.
Members access an array of sophisticated screenings. This includes advanced blood testing. Whole-body MRIs offer detailed views. DEXA scans assess bone density. VO2 max measures cardiovascular fitness. ECGs monitor heart health. Isometric strength tests gauge physical capacity. Continuous glucose monitoring tracks metabolic health. Food journal analysis refines dietary habits. CT coronary angiograms detect heart issues early. These diagnostics pair with continuous support. Members receive personalized prevention plans. The flagship Protocol membership exemplifies this. It provides year-round diagnostics. Clinically guided interventions follow. This comprehensive approach comes at a fraction of traditional care costs. It makes premium prevention accessible.
At Everlab’s core lies its proprietary clinical platform. This full-stack system leverages powerful AI agents. These agents ingest vast amounts of complex health data. They analyze and interpret this information. The AI automates clinical summaries. It identifies early risk markers. It recommends precise next steps. This frees physicians from administrative burdens. Doctors focus on patient care. They deliver earlier, more precise interventions.
Deep integrations connect Everlab to the existing healthcare infrastructure. It links with national pathology networks. It integrates with radiology networks. This creates a real-time, longitudinal health record for every member. The platform seamlessly embeds within the current system. It enhances, not replaces, clinical workflows.
Everlab’s early momentum is impressive. Tens of thousands of customers populate its waitlist. Demand grows across consumer and enterprise markets. The company projects twenty-fold growth this year. Its go-to-market strategy positions Everlab as a leader. It delivers high-quality, prevention-focused care at scale.
The impact of Everlab’s approach is tangible. The company has processed over 1,000,000 biomarkers. These come from full-body health testing. The findings are sobering. One in four test results show abnormalities. For 2.5% of members, discoveries are life-changing. These include blocked arteries. Gastrointestinal tumors have been found. Early-stage cancers and congenital brain abnormalities surface. Early detection leads to timely treatment. This saves lives.
Beyond diagnostics, Everlab provides data-driven interventions. These are highly personalized. They align with each member’s risk profile. They target individual health goals. Retesting reveals significant improvements. A meta-analysis of members showed progress. Over one-third of modifiable biomarkers improved within six months. This demonstrates the model’s concrete health impact. Everlab transitions individuals from at-risk to healthier states.
The new funding round ensures continued progress. Everlab will expand its clinic network. It will grow its engineering team. Its clinical team will also expand. The company will advance its AI-powered infrastructure. This lays the foundation for a truly global system. It builds scalable preventive healthcare. Everlab transforms medical ideals into commercial reality. It combines clinical depth with software leverage. Operational precision makes it scalable. The company builds a category-defining platform. It sets a new standard for proactive health management.
Everlab heralds a new era in health. It moves healthcare from reactive treatment to proactive prevention. It harnesses AI. It empowers individuals. It supports clinicians. The focus shifts to lifelong wellness. This innovative model promises to redefine health outcomes for millions globally. It makes personalized, preventive care accessible. This is the future of health.